InvestorsHub Logo
Followers 33
Posts 5288
Boards Moderated 0
Alias Born 01/23/2019

Re: None

Thursday, 10/15/2020 5:15:48 PM

Thursday, October 15, 2020 5:15:48 PM

Post# of 425656
BRIEF-Vascepa (Icosapent Ethyl) Found To Significantly Reduce Ischemic Events In Patients With Prior Percutaneous Coronary Intervention In Post HOC Subgroup Analyses Of Landmark Reduce-It Study
REUTERS 5:14 PM ET 10/15/2020
Symbol Last Price Change
AMRN 5.05down +0.1 (+2.0202%)
QUOTES AS OF 04:00:00 PM ET 10/15/2020
Oct 15 (Reuters) - Amarin Corporation PLC(AMRN):

* VASCEPA® (ICOSAPENT ETHYL) FOUND TO SIGNIFICANTLY REDUCE ISCHEMIC EVENTS IN PATIENTS WITH PRIOR PERCUTANEOUS CORONARY INTERVENTION (PCI) IN POST HOC SUBGROUP ANALYSES OF LANDMARK REDUCE-IT® STUDY PRESENTED AT TRANSCATHETER CARDIOVASCULAR THERAPEUTICS (TCT) CONNECT 2020 Source text for Eikon: Further company coverage:

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News